TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33483796

Group type: EXPERIMENTAL
Intervention: Coordinator intervention (LI)
Number of subjects: 141
Study: 33647900

Group type: EXPERIMENTAL
Intervention: Serotonin (5-HT) agonistic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noradrenaline (NA) agonistic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dopamine (DA) agonistic drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35273377

Group type: EXPERIMENTAL
Intervention: Supervised exercise (aerobic and resistance) for 16 weeks, starting 4 weeks before initiation of ADT and enzalutamide
Number of subjects: 26

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 26
Study: 32928167

Group type: EXPERIMENTAL
Intervention: Metformin in addition to a diet and lifestyle intervention
Number of subjects: 511

Group type: COMPARATOR
Intervention: Diet and lifestyle intervention alone (Control)
Number of subjects: 511
Study: 35407378

Group type: EXPERIMENTAL
Intervention: Remote Ischaemic Preconditioning (RIPC)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no RIPC)
Number of subjects: 47
Study: 32218251

Group type: EXPERIMENTAL
Intervention: Web-based intervention with additional initial face-to-face contact
Number of subjects: 336

Group type: COMPARATOR
Intervention: Web-based intervention
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Health-related skill ‘dealing with health information’
Number of subjects: 336
Study: 33386508

Group type: EXPERIMENTAL
Intervention: VIP-HANA app
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control app (report symptoms only)
Number of subjects: 100
Study: 32998401

Group type: EXPERIMENTAL
Intervention: High personalisation (access to 'Body Balance Beyond' website, individual telehealth coaching via video call, text message support)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Low personalisation (website only)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High personalisation group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Text messages
Number of subjects: 42
Study: 36149885

Group type: EXPERIMENTAL
Intervention: Combination of 2.5 mg of letrozole and 50 mg of clomiphene citrate (CC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Letrozole alone (2.5 mg)
Number of subjects: 80
Study: 34120608

Group type: EXPERIMENTAL
Intervention: House Improvement (HI)
Number of subjects: 25000

Group type: EXPERIMENTAL
Intervention: Larval Source Management (LSM)
Number of subjects: 25000

Group type: EXPERIMENTAL
Intervention: House Improvement + Larval Source Management (HI + LSM)
Number of subjects: 25000
Study: 35125106

Group type: EXPERIMENTAL
Intervention: Tai Chi (n=32)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Brisk walking (n=31)
Number of subjects: 95

Group type: COMPARATOR
Intervention: No-exercise (n=32)
Number of subjects: 95
Study: 33313925

Group type: EXPERIMENTAL
Intervention: Nap (90-min nap from 14:00-15:30)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: HN-nap
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: NN-nap
Number of subjects: 92

Group type: COMPARATOR
Intervention: HN-wake
Number of subjects: 92

Group type: COMPARATOR
Intervention: NN-wake
Number of subjects: 92
Study: 35980909

Group type: EXPERIMENTAL
Intervention: Expectation for learning group (reactivation with expectation)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: No expectation for learning group (reactivation without expectation)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No reactivation group (no reactivation)
Number of subjects: 48
Study: 33886495

Group type: EXPERIMENTAL
Intervention: GIP(3-30)NH2 (1200 pmol/kg/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10
Study: 32440838

Group type: EXPERIMENTAL
Intervention: Transvaginal polypropylene mesh (PM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Anterior colporrhaphy (AC)
Number of subjects: 100
Study: 35653788

Group type: EXPERIMENTAL
Intervention: Low trans fatty acids (TFAs) dietary patterns during pregnancy (< 1% TFAs content)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Control group with no change in TFAs content
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Low trans fatty acids (TFAs) dietary patterns during pregnancy
Number of subjects: 800
Study: 34049171

Group type: EXPERIMENTAL
Intervention: Sulfurous-arsenical-ferruginous thermal water inhalation (hot humid air and aerosol)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Combined inhalation and nasal irrigation of sulfurous-arsenical-ferruginous thermal water
Number of subjects: 253
Study: 33289067

Group type: EXPERIMENTAL
Intervention: Practices with higher edge density
Number of subjects: 449460

Group type: EXPERIMENTAL
Intervention: Practices with higher degree centralization
Number of subjects: 449460
Study: 34119901

Group type: EXPERIMENTAL
Intervention: Autologous mesenchymal stem cell therapy (MSC)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Second course of MSC therapy
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard treatment with AEDs
Number of subjects: 67
Study: 33221071

Group type: EXPERIMENTAL
Intervention: Cash incentive ($25, $50) to see a PCP
Number of subjects: 981
Study: 35875009

Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion
Number of subjects: 90

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 90
Study: 32358836

Group type: EXPERIMENTAL
Intervention: 1:1:1 transfusion ratio of plasma and platelets to red blood cells
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: 1:1:1 transfusion ratio
Number of subjects: 680

Group type: COMPARATOR
Intervention: 1:1:2 transfusion ratio
Number of subjects: 680
Study: 35837793

Group type: EXPERIMENTAL
Intervention: risdiplam
Number of subjects: 51

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 51
Study: 33406269

Group type: EXPERIMENTAL
Intervention: Benzoate (250-1500 mg/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 33851258

Group type: EXPERIMENTAL
Intervention: Stimulating dissector (SD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intermittent stimulating probe (ISP)
Number of subjects: 32
Study: 32747208

Group type: EXPERIMENTAL
Intervention: Tailored follow-up by a multidisciplinary team
Number of subjects: 301

Group type: COMPARATOR
Intervention: No follow-up (Control)
Number of subjects: 301
Study: 34981231

Group type: EXPERIMENTAL
Intervention: Merged Virtual Reality (MVR) platform
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Standard in-person instruction
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (practice without feedback)
Number of subjects: 30
Study: 34266464

Group type: EXPERIMENTAL
Intervention: Health consultation and decision aid using a novel expected frequency tree (EFT)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 258
Study: 33567390

Group type: EXPERIMENTAL
Intervention: Psychological treatments for BED
Number of subjects: 110
Study: 32438245

Group type: EXPERIMENTAL
Intervention: VAC + ITM (MLV-vaccine and ITM - Multimin®90 subcutaneously)
Number of subjects: 45

Group type: COMPARATOR
Intervention: VAC + SAL (MLV-vaccine and saline)
Number of subjects: 45

Group type: COMPARATOR
Intervention: UNVAC (unvaccinated)
Number of subjects: 45
Study: 35050948

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) at 32‐34 °C
Number of subjects: 3988

Group type: COMPARATOR
Intervention: Control (normothermia or temperature ≥36 °C)
Number of subjects: 3988
Study: 33653744

Group type: EXPERIMENTAL
Intervention: Flash glucose monitoring (FGM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose
Number of subjects: 100
Study: 33092805

Group type: EXPERIMENTAL
Intervention: Minimally invasive intraoperative goal-directed therapy (GDT)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Control group (haemodynamic management left to the discretion of attending senior anaesthetists)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: GDT
Number of subjects: 232
Study: 35709823

Group type: EXPERIMENTAL
Intervention: Short-term anti-TNF therapy with surgical closure
Number of subjects: 56

Group type: COMPARATOR
Intervention: Anti-TNF therapy
Number of subjects: 56
Study: 33539371

Group type: EXPERIMENTAL
Intervention: Two family meals regularly
Number of subjects: 2743

Group type: EXPERIMENTAL
Intervention: One regular family meal
Number of subjects: 2743

Group type: COMPARATOR
Intervention: No regular family meals
Number of subjects: 2743
Study: 32982203

Group type: EXPERIMENTAL
Intervention: St. George’s Respiratory Questionnaire (SGRQ) - Symptoms domain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: St. George’s Respiratory Questionnaire (SGRQ) - Activity domain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exploratory RMT analysis for 'Cough and Sputum', 'Breathing difficulties', 'Wheezing attacks'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross-cultural analysis of SGRQ 'Activity' items
Number of subjects: 0
Study: 34634246

Group type: EXPERIMENTAL
Intervention: Thoracic ultrasonography-guided care
Number of subjects: 313

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 313
Study: 32593253

Group type: EXPERIMENTAL
Intervention: Inactive vitamin D treatment maintaining levels >34.3 ng/ml for 12 months
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Inactive vitamin D treatment
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control group treatment according to recommendations of the Russian Association of Endocrinologists
Number of subjects: 264
Study: 35522534

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (early-PN)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Late parenteral nutrition (late-PN)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Healthy control children
Number of subjects: 614
Study: 33891378

Group type: EXPERIMENTAL
Intervention: Salvage robotic prostatectomy (S-RARP)
Number of subjects: 24
Study: 32438138

Group type: EXPERIMENTAL
Intervention: External Pop-out (EPO) technique
Number of subjects: 910

Group type: COMPARATOR
Intervention: Classic technique
Number of subjects: 910
Study: 32773596

Group type: EXPERIMENTAL
Intervention: Combined interventions (sucrose, massage, music, non-nutritive sucking, gentle human touch)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combined interventions
Number of subjects: 76

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 76
Study: 32310005

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (performed at least twice within 6 weeks)
Number of subjects: 182901

Group type: COMPARATOR
Intervention: Control group (no acupuncture treatment)
Number of subjects: 182901
Study: 33211517

Group type: EXPERIMENTAL
Intervention: Web‐PE
Number of subjects: 74

Group type: COMPARATOR
Intervention: PCT
Number of subjects: 74
Study: 32557087

Group type: EXPERIMENTAL
Intervention: POC coagulation tests
Number of subjects: 162

Group type: COMPARATOR
Intervention: Conventional laboratory coagulation tests (control group)
Number of subjects: 162
Study: 34389374

Group type: EXPERIMENTAL
Intervention: Vegetable-related norm message
Number of subjects: 12994

Group type: COMPARATOR
Intervention: Neutral-behavior norm message (Control)
Number of subjects: 12994
Study: 35290614

Group type: EXPERIMENTAL
Intervention: Valvular surgery
Number of subjects: 912

Group type: COMPARATOR
Intervention: Surgery performed
Number of subjects: 912
Study: 34542038

Group type: EXPERIMENTAL
Intervention: Low-frequency (LF-) rTMS (n=14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham-rTMS (n=14)
Number of subjects: 28
Study: 36207143

Group type: EXPERIMENTAL
Intervention: Immersion in water at 20‐30°C (20 min/day for 4 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study: 33973300

Group type: EXPERIMENTAL
Intervention: Linked Color Imaging (LCI)
Number of subjects: 995

Group type: COMPARATOR
Intervention: White Light Imaging (WLI)
Number of subjects: 995
Study: 32730920

Group type: EXPERIMENTAL
Intervention: GIP receptor antagonist GIP(3-30)NH2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor antagonist exendin(9–39)NH2
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both GIP(3-30)NH2 and exendin(9–39)NH2
Number of subjects: 30
Study: 34791018

Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 29

Group type: COMPARATOR
Intervention: Traditional surgery
Number of subjects: 29
Study: 34628926

Group type: EXPERIMENTAL
Intervention: Loose combined cutting seton (LCCS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Traditional cutting seton (CS)
Number of subjects: 76
Study: 35181200

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 34031240

Group type: EXPERIMENTAL
Intervention: Storytelling intervention (30 minutes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control (solving riddles with social interaction)
Number of subjects: 0
Study: 36434687

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT) for 20 min per session, 6 sessions total, once every two days.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise (TE) for 30 min per session, 6 sessions total, once every two days.
Number of subjects: 17
Study: 33532952

Group type: EXPERIMENTAL
Intervention: e-Familias Unidas
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study: 32564453

Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (BAK)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Preservative-free (PF)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Polyquad (PQ)
Number of subjects: 36
Study: 35352382

Group type: EXPERIMENTAL
Intervention: Inclusion of unexposed clusters in fixed effects LSDV analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard fixed effects LSDV analysis without unexposed clusters
Number of subjects: 0
Study: 34153318

Group type: EXPERIMENTAL
Intervention: 11β-MNTDC
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 36180142

Group type: EXPERIMENTAL
Intervention: Pilates method (PM) protocol, 16 sessions, twice a week (n=33)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (CG) without intervention (n=29)
Number of subjects: 62
Study: 33737427

Group type: EXPERIMENTAL
Intervention: Use of Pozzi tenaculum forceps during IUI
Number of subjects: 800

Group type: COMPARATOR
Intervention: Standard care treatment without Pozzi tenaculum forceps during IUI
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Standard care treatment with Pozzi tenaculum forceps during IUI
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Interventions performed by attendings
Number of subjects: 800
Study: 35218680

Group type: EXPERIMENTAL
Intervention: Intralesional platelet-rich plasma (PRP) injections
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intralesional triamcinolone acetonide (TA) injections
Number of subjects: 20
Study: 32715653

Group type: EXPERIMENTAL
Intervention: Pharmacist-managed dosing algorithm for darbepoetin alfa (DA) and iron sucrose
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study: 34126650

Group type: EXPERIMENTAL
Intervention: 3D macula scan method (3DM)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Line scan method 1 (LM1)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Line scan method 2 (LM2)
Number of subjects: 39
Study: 34403548

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral midazolam
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 4 µg/kg oral clonidine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2 µg/kg intranasal dexmedetomidine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 32016407

Group type: EXPERIMENTAL
Intervention: Alternative condition with graphical opioid history and noninterruptive CDS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional condition with tabular format and interruptive modal dialogs
Number of subjects: 24
Study: 35370406

Group type: EXPERIMENTAL
Intervention: CFHealthHub intervention (objective adherence data)
Number of subjects: 22
Study: 32890429

Group type: EXPERIMENTAL
Intervention: Fibromyalgia Self-Management Programme (FSMP)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control arm (not specified)
Number of subjects: 70
Study: 34855419

Group type: COMPARATOR
Intervention: Standard weight loss intervention
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Intervention with training to enhance autonomy support behavior
Number of subjects: 64
Study: 34454458

Group type: EXPERIMENTAL
Intervention: Physiotherapist-delivered pain science education (PSE) integrated with an individualised walking, strengthening, and general education program
Number of subjects: 198

Group type: COMPARATOR
Intervention: Individualised physiotherapist-led walking, strengthening, and OA/activity education program
Number of subjects: 198
Study: 34559601

Group type: EXPERIMENTAL
Intervention: menthol
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 32819404

Group type: EXPERIMENTAL
Intervention: Vertebral cancellous bone infiltration anaesthesia
Number of subjects: 112

Group type: COMPARATOR
Intervention: Local anaesthesia alone
Number of subjects: 112
Study: 35930062

Group type: EXPERIMENTAL
Intervention: Severe disc degeneration (Pfirrmann score 4-5)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Other preoperative MRI findings
Number of subjects: 437
Study: 32228512

Group type: EXPERIMENTAL
Intervention: gemcitabine + nab-paclitaxel (1000 mg/m2 gemcitabine + 125 mg/m2 nab-paclitaxel)
Number of subjects: 125

Group type: COMPARATOR
Intervention: gemcitabine alone (1000 mg/m2)
Number of subjects: 125
Study: 35862454

Group type: EXPERIMENTAL
Intervention: Targeting pairs of friends (pair targeting)
Number of subjects: 2491

Group type: EXPERIMENTAL
Intervention: Friendship nomination targeting
Number of subjects: 2491

Group type: EXPERIMENTAL
Intervention: Targeting 20% of women at random
Number of subjects: 2491

Group type: COMPARATOR
Intervention: No targeting
Number of subjects: 2491
Study: 33404620

Group type: EXPERIMENTAL
Intervention: Machine learning alerts for dispatcher recognition of OHCA
Number of subjects: 654

Group type: COMPARATOR
Intervention: Standard protocols without machine learning assistance
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: Machine learning alerts
Number of subjects: 654

Group type: COMPARATOR
Intervention: Standard protocols without alerts
Number of subjects: 654
Study: 32976320

Group type: EXPERIMENTAL
Intervention: Visual transient elastography (ViTE)
Number of subjects: 227

Group type: COMPARATOR
Intervention: FibroScan (FS)
Number of subjects: 227
Study: 35155865

Group type: EXPERIMENTAL
Intervention: Steroid avoidance protocol (tacrolimus/MMF/antithymocyte globulin [ATG] induction)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Steroid maintenance protocol (tacrolimus/MMF/prednisolone/basiliximab-induction)
Number of subjects: 222
Study: 32535191

Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for automated grading of CD ulcers on capsule endoscopy images
Number of subjects: 49

Group type: COMPARATOR
Intervention: Consensus reading by 3 capsule readers
Number of subjects: 49
Study: 33394524

Group type: EXPERIMENTAL
Intervention: Self-swabbing
Number of subjects: 190

Group type: COMPARATOR
Intervention: Conventional swabbing
Number of subjects: 190
Study: 36315143

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Moderate to Vigorous Intensity Continuous Training (CR)
Number of subjects: 86
Study: 33548689

Group type: EXPERIMENTAL
Intervention: Sobriety Treatment and Recovery Teams (START)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Usual child welfare services
Number of subjects: 348
Study: 34807274

Group type: EXPERIMENTAL
Intervention: RIRS
Number of subjects: 121

Group type: COMPARATOR
Intervention: PCNL
Number of subjects: 121
Study: 34357477

Group type: EXPERIMENTAL
Intervention: Expressive writing intervention (three 15-min sessions)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group writing sessions (equivalent to expressive writing)
Number of subjects: 78
Study: 33860035

Group type: EXPERIMENTAL
Intervention: Three-dimensional balanced manipulation (TBM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional massage (Control)
Number of subjects: 120
Study: 35803777

Group type: EXPERIMENTAL
Intervention: Alveogyl dressings in extraction sites changed every 48 hours until cessation of pain (Group 2)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: PBMT following mechanical curettage and Alveogyl dressing (Group 3)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: PBMT only (Group 4)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Mechanical curettage (Group 1)
Number of subjects: 55
Study: 34391295

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) applied to the gastrocnemius muscle
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) applied to the erector spinae muscle
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) applied to the infraspinatus muscle
Number of subjects: 60
Study: 32053696

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study: 33577117

Group type: EXPERIMENTAL
Intervention: Intervention group (school environmental strategies targeting SSB availability, placement, promotion, pricing, and increased water availability)
Number of subjects: 862

Group type: COMPARATOR
Intervention: Control group (usual programmes)
Number of subjects: 862
Study: 34236624

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various therapies (pharmacologic, electromagnetic, mechanical, sensory, regenerative)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Precision medicine approach
Number of subjects: 0
Study: 36127075

Group type: EXPERIMENTAL
Intervention: TRE with behavioural economic interventions (financial incentives and text reminders)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: TRE alone
Number of subjects: 114

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: TRE with behavioural economic interventions
Number of subjects: 114